Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is There Any Hope Left for Sage Therapeutics?


Mid-cap biotech Sage Therapeutics (NASDAQ: SAGE) has been a lackluster performer lately. Shares have declined by nearly 80% over the past 12 months. Meanwhile, the S&P 500 is up over 12% in the same period.

Will the company be able to recover from its setbacks and deliver promising pipeline results for shareholders? Let's find out.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments